Colgate-Palmolive's Upcoming Q3 Earnings Report
Colgate-Palmolive Company (NYSE: CL) is set to unveil its earnings results for the third quarter soon. Investors and analysts are keenly anticipating this announcement, as it provides critical insights into the company’s performance and market strategies.
Analysts’ Earnings Expectations
Market analysts forecast that Colgate-Palmolive will report earnings of 88 cents per share in the upcoming quarter. This reflects a slight increase from last year's earnings of 86 cents per share, indicating growth for the company.
Projected Quarterly Revenue
In addition to earnings per share, projections reveal that Colgate-Palmolive is expected to generate approximately $5 billion in revenue during this quarter. This significant revenue figure demonstrates the company's resilience and ability to maintain strong sales amid evolving market conditions.
Latest Dividend Announcement
On September 12, Colgate-Palmolive's board announced a quarterly cash dividend of 50 cents per common share, which is a noteworthy detail for investors who prioritize income-generating stocks. These dividends are crucial as they reflect the company’s commitment to returning value to its shareholders.
Performance of Colgate-Palmolive Shares
Recently, Colgate-Palmolive shares saw a 0.8% increase, closing at $99.74. This uptick is indicative of the market’s positive outlook on the stock and investor confidence leading up to the earnings report.
Recent Analyst Ratings
In the past few weeks, several analysts have weighed in on Colgate-Palmolive’s stock. Here’s a breakdown of the latest ratings:
- JP Morgan's Andrea Teixeira maintained an Overweight rating, raising the price target from $113 to $114 on October 11 with a 61% accuracy rate.
- Wells Fargo's Chris Carey downgraded the stock from Equal-Weight to Underweight, setting a price target of $100 on September 16, an analyst with a 66% accuracy rate.
- Deutsche Bank's Steve Powers downgraded the stock from Buy to Hold, while adjusting the price target from $107 to $109 on September 9, achieving an accuracy of 68%.
- TD Cowen's Robert Moskow maintained a Buy rating and increased the price target from $110 to $115 on July 30 with a 67% accuracy rate.
- Morgan Stanley's Dara Mohsenian reaffirmed an Overweight rating with an increase in the price target from $103 to $111 on July 29, boasting a 72% accuracy rate.
These ratings highlight the varying perspectives within the investment community regarding Colgate-Palmolive’s potential for growth and price appreciation.
What to Consider Before Investing
If you’re contemplating investing in Colgate-Palmolive (CL), it’s essential to review what analysts are saying. Their insights may provide you with guidance on the stock’s future performance and any potential triggers that could influence its price.
Frequently Asked Questions
What are the expected earnings for Colgate-Palmolive this quarter?
Analysts expect Colgate-Palmolive will report earnings of 88 cents per share for the third quarter.
What is the projected revenue for Colgate-Palmolive?
The projected revenue for Colgate-Palmolive this quarter is approximately $5 billion.
What is the latest dividend declared by Colgate-Palmolive?
The company announced a quarterly cash dividend of 50 cents per common share.
How did Colgate-Palmolive shares perform recently?
Colgate-Palmolive shares rose by 0.8% to close at $99.74.
What have analysts recently said about Colgate-Palmolive?
Analysts have provided various ratings, indicating a mix of buy, hold, and sell assessments with different price targets.
